XOMA Royalty (XOMA) Shares Outstanding (Diluted Average) (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Shares Outstanding (Diluted Average) came in at $17.4 million in Q1 2026, down 2.05% year-on-year from $17.8 million in Q1 2025, and down 3.14% quarter-over-quarter from $18.0 million in Q4 2025.

XOMA Royalty (XOMA) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Shares Outstanding (Diluted Average) across 16 years of filings, most recently posting $17.4 million for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $17.4 million, down 2.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.4 million (down 2.05% YoY), and the FY2025 annual result was $18.0 million, up 53.68% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $17.4 million for Q1 2026 at XOMA Royalty, down from $18.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $18.1 million in Q3 2025 to a low of $11330.0 in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $11.7 million (2024), against an average of $11.0 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) slumped 99.9% in 2022 and soared 100947.12% in 2024, its largest moves.
  • XOMA Royalty's Shares Outstanding (Diluted Average) stood at $11400.0 in 2022, then surged by 100540.35% to $11.5 million in 2023, then rose by 1.99% to $11.7 million in 2024, then surged by 53.68% to $18.0 million in 2025, then dropped by 3.14% to $17.4 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $17.4 million (Q1 2026), $18.0 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 256.30 Mn
9 Abivax 95.45 Bn 95.45 Bn - 92.44 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 17.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17.42 Mn
Dec 31, 2025 17.98 Mn
Sep 30, 2025 18.14 Mn
Jun 30, 2025 17.78 Mn
Mar 31, 2025 17.78 Mn
Dec 31, 2024 11.70 Mn
Sep 30, 2024 11.71 Mn
Jun 30, 2024 17.32 Mn
Mar 31, 2024 11.58 Mn
Sep 30, 2023 11.47 Mn
Jun 30, 2023 11.46 Mn
Mar 31, 2023 11,460.00
Sep 30, 2022 11,400.00
Jun 30, 2022 11,376.00
Mar 31, 2022 11,330.00
Sep 30, 2021 11.31 Mn
Jun 30, 2021 11.26 Mn
Mar 31, 2021 11.24 Mn
Sep 30, 2020 10.54 Mn
Mar 31, 2020 9.76 Mn